Diseases associated with the anti-Ma2 antibody are at a high risk (>75%) of tumor co-existence, which primarily includes testicular tumors and non-small-cell lung cancer (NSCLC) [39]. The gene discussed is PNMA2; the disease is non-small cell lung carcinoma.